New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases

New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases

Background: Notably, 5-aminosalicylates (5-ASA) are vital in treating inflammatory bowel diseases (IBD). The adverse events of 5-ASA rarely occur but they could be fatal. Objectives: We aimed to discover new genetic biomarkers predicting 5-ASA-induced adverse events in patients with IBD. Design: Thi...

Full description

Bibliographic Details
Main Authors:	Jihye Park, I. Seul Park, Ji Hyung Kim, Jung Hyun Ji, Soo Jung Park, Jae Jun Park, Tae Il Kim, Seung Won Kim, Jae Hee Cheon
Format:	Article
Language:	English
Published:	SAGE Publishing 2024-01-01
Series:	Therapeutic Advances in Gastroenterology
Online Access:	https://doi.org/10.1177/17562848241227029

Similar Items

Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
by: Jihye Park, et al.
Published: (2022-09-01)

Probe-based confocal laser endomicroscopy in the differential diagnosis of inflammatory bowel diseases: a case series
by: Jung Won Park, et al.
Published: (2018-10-01)

Resting heart rate is an independent predictor of advanced colorectal adenoma recurrence.
by: Jihye Park, et al.
Published: (2018-01-01)

Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease
by: Hye Kyung Hyun, et al.
Published: (2024-03-01)

Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience
by: Jihye Park, et al.
Published: (2018-04-01)

Prevalence and risk factors for gallstone and renal stone formation in patients with intestinal Behçet’s disease
by: Jaewon Song, et al.
Published: (2024-09-01)

Clinical characteristics and risk factors related to polyposis recurrence and advanced neoplasm development among patients with non-hereditary colorectal polyposis
by: Jihun Jang, et al.
Published: (2023-10-01)

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
by: Jihye Park, et al.
Published: (2021-09-01)

Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease
by: Hui Won Jang, et al.
Published: (2016-10-01)

Usefulness of Measuring Serum Procalcitonin Levels in Patients with Inflammatory Bowel Disease
by: Sook Hee Chung, et al.
Published: (2016-07-01)

Effects of COVID-19 vaccines on patient-reported outcomes in patients with inflammatory bowel disease: a multicenter survey study in Korea
by: Jung Hyun Ji, et al.
Published: (2024-07-01)

Development of a Novel Endoscopic Scoring System to Predict Relapse after Surgery in Intestinal Behçet’s Disease
by: Jung Won Park, et al.
Published: (2018-11-01)

Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
by: Jihye Park, et al.
Published: (2021-09-01)

Effectiveness and tolerability of methotrexate monotherapy in Crohn’s disease patients: a multicenter observational study
by: Jihye Park, et al.
Published: (2023-08-01)

Primary surgery versus pharmacotherapy for newly diagnosed ileocecal Crohn’s disease: a hospital-based cohort study
by: Yehyun Park, et al.
Published: (2024-09-01)

Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis
by: Jongwook Yu, et al.
Published: (2021-11-01)

Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Behçet’s disease
by: Jihye Park, et al.
Published: (2023-03-01)

Rebleeding Rate and Risk Factors for Rebleeding after Device-Assisted Enteroscopy in Patients with Obscure Gastrointestinal Bleeding: A KASID Multicenter Study
by: Yuna Kim, et al.
Published: (2022-04-01)

Incidence and risk factors of micronutrient deficiency in patients with IBD and intestinal Behçet’s disease: folate, vitamin B12, 25-OH-vitamin D, and ferritin
by: Yong Eun Park, et al.
Published: (2021-01-01)

The relationship between diverticulosis and colorectal neoplasia: A meta-analysis.
by: Hyun Jung Lee, et al.
Published: (2019-01-01)

Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn’s Disease Recurrence
by: Jongwook Yu, et al.
Published: (2022-05-01)

Radiology plus ileocolonoscopy versus radiology alone in Crohn’s disease: prognosis prediction and mutual agreement
by: Hye Kyung Hyun, et al.
Published: (2022-05-01)

Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis
by: Soo-Kyung Park, et al.
Published: (2022-09-01)

Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn’s disease in patients with prior failure of anti-tumour necrosis factor treatment
by: Hye Kyung Hyun, et al.
Published: (2022-03-01)

Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function
by: Mijeong Son, et al.
Published: (2022-05-01)

Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model
by: Jihye Park, et al.
Published: (2021-10-01)

Comparison of Long-Term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naïve Patients with Ulcerative Colitis
by: Yong Il Lee, et al.
Published: (2021-03-01)

Impact of Visceral Fat on Survival and Metastasis of Stage III Colorectal Cancer
by: Jung Won Park, et al.
Published: (2022-01-01)

Long-Term Outcomes of Endoscopic Balloon Dilation for Benign Strictures in Patients with Inflammatory Bowel Disease
by: Hye Won Lee, et al.
Published: (2018-09-01)

C-reactive protein is associated with postoperative outcomes in patients with intestinal Behçet’s disease
by: Eun Ae Kang, et al.
Published: (2021-10-01)

Effects of Perianal Involvement on Clinical Outcomes in Crohn’s Disease over 10 Years
by: Jin Young Yoon, et al.
Published: (2018-05-01)

Effect of Colostrum on the Symptoms and Mucosal Permeability in Patients with Irritable Bowel Syndrome: A Randomized Placebo-controlled Study
by: Jin Young Yoon, et al.
Published: (2014-01-01)

Aminosalicylates in inflammatory bowel disease
by: Vojislav N. Perisic
Published: (2013-10-01)

Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis.
by: Jin Lee, et al.
Published: (2019-01-01)

Anti-inflammatory properties of butyrate-producing atypical in a murine colitis model
by: Ji Hyung Kim, et al.
Published: (2023-04-01)

Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases
by: Jung Min Kim, et al.
Published: (2020-07-01)

Downregulation of Heat Shock Protein 72 Contributes to Fibrostenosis in Crohn’s Disease
by: Seung Won Kim, et al.
Published: (2023-11-01)

TRIM40 is a pathogenic driver of inflammatory bowel disease subverting intestinal barrier integrity
by: Sujin Kang, et al.
Published: (2023-02-01)

Changes in geriatric nutritional risk index and risk of major adverse cardiac and cerebrovascular events in incident peritoneal dialysis patients
by: Mi Jung Lee, et al.
Published: (2017-12-01)

Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet’s Disease
by: Jihye Park, et al.
Published: (2018-11-01)